13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$2.46B
−26% on the quarter before
Positions
194
12 new · 20 sold out
Top 10
44.6%
of the value
Est. gain
−$610.4M
on stocks held all quarter
Est. return
−23.4%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$79.5MAdded · 2.7% → 5.0%+595,286 shares
- Block~$61.9MAdded · 3.1% → 4.9%+1,104,170 shares
- Teladoc Health Inc~$28.2MAdded · 0.2% → 1.3%+568,616 shares
- Teradyne~$27.0MAdded · 1.9% → 3.3%+859,222 shares
- Zillow Group Inc~$26.3MAdded · 1.3% → 2.3%+833,607 shares
- Lendingtree Inc~$19.4MAdded · 1.0% → 2.1%+88,341 shares
- Baidu~$19.0MAdded · 4.2% → 4.7%+120,018 shares
- 2u Inc~$19.0MAdded · 0.4% → 1.2%+381,643 shares
- Netflix~$15.1MAdded · 2.3% → 2.8%+56,549 shares
- Splunk Inc~$14.5MAdded · 1.3% → 2.1%+138,630 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$110.7MCut · 6.0% → 5.6%−332,618 shares
- Red Hat Inc~$75.9MCut · 1.8% → 0.0%−433,808 shares
- Jd.Com Inc~$68.6MCut · 2.7% → 0.1%−3,280,113 shares
- Pacific Biosciences Of Califor~$52.8MCut · 1.3% → 0.0%−7,785,895 shares
- Xilinx Inc~$45.2MCut · 1.5% → 0.4%−531,290 shares
- Aptiv Plc~$32.0MCut · 1.6% → 0.2%−519,343 shares
- MercadoLibre~$29.5MCut · 1.3% → 0.3%−100,582 shares
- TSMC~$27.6MCut · 1.3% → 0.4%−747,233 shares
- Twitter Inc~$25.9MCut · 3.5% → 3.8%−899,852 shares
- Apple~$25.4MCut · 1.8% → 0.7%−161,330 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −45% · price +25.7% | 5.6% | $137.8M | +$28.2M | ||||||||
| NvidiaCommon Stock · shares +187% · price −52.5% | 5.0% | $122.0M | −$47.0M | ||||||||
| Stratasys LtdCommon Stock · shares −2.0% · price −22.1% | 5.0% | $122.0M | −$34.5M | ||||||||
| BlockCommon Stock · shares +107% · price −43.3% | 4.9% | $119.8M | −$44.3M | ||||||||
| BaiduADR · shares +20% · price −30.6% | 4.7% | $115.7M | −$42.7M | ||||||||
| Tencent Holdings LtdADR · shares −4.0% · price −3.4% | 4.2% | $103.2M | −$3.6M | ||||||||
| Invitae CorpCommon Stock · shares −4.4% · price −33.9% | 3.9% | $97.0M | −$49.7M | ||||||||
| Illumina IncCommon Stock · shares +17% · price −18.3% | 3.9% | $95.0M | −$18.2M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +18% · price −52.3% | 3.8% | $92.8M | −$86.1M | ||||||||
| Twitter IncCommon Stock · shares −22% · price +1.0% | 3.8% | $92.6M | +$902,818 | ||||||||
| TeradyneCommon Stock · shares +50% · price −15.1% | 3.3% | $81.3M | −$9.7M | ||||||||
| NetflixCommon Stock · shares +27% · price −28.5% | 2.8% | $70.2M | −$21.9M | ||||||||
| Editas Medicine IncCommon Stock · shares +8.3% · price −28.5% | 2.8% | $68.8M | −$25.3M | ||||||||
| AmazonCommon Stock · shares +13% · price −25.0% | 2.6% | $64.3M | −$19.1M | ||||||||
| Medidata Solutions IncCommon Stock · shares +16% · price −8.0% | 2.6% | $63.1M | −$4.7M | ||||||||
| Zillow Group IncCommon Stock · shares +84% · price −28.6% | 2.3% | $57.5M | −$12.5M | ||||||||
| Splunk IncCommon Stock · shares +39% · price −13.3% | 2.1% | $52.2M | −$5.8M | ||||||||
| Lendingtree IncCommon Stock · shares +60% · price −4.6% | 2.1% | $51.7M | −$1.6M | ||||||||
| Materialise NvADR · shares −2.8% · price +45.1% | 2.0% | $49.3M | +$15.3M | ||||||||
| SalesforceCommon Stock · shares +41% · price −13.9% | 2.0% | $48.5M | −$5.5M | ||||||||
| Nanostring Technologies IncCommon Stock · shares −5.7% · price −16.8% | 2.0% | $48.0M | −$9.7M | ||||||||
| Lendingclub CorpCommon Stock · shares −2.6% · price −32.2% | 1.9% | $46.1M | −$21.9M | ||||||||
| Spotify Technology SaCommon Stock · shares +43% · price −37.2% | 1.8% | $44.9M | −$18.7M | ||||||||
| Veracyte IncCommon Stock · shares −11% · price +31.7% | 1.8% | $43.9M | +$10.6M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −8.8% · price −35.6% | 1.5% | $37.9M | −$20.9M | ||||||||
| Total · 194 positions | 100% | $2.46B | −$610.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 182 stocks held throughout, down $610.4M (−23.4%).
- Tesla+$28.2M+26%
- Materialise Nv+$15.3M+45%
- Veracyte Inc+$10.6M+32%
- Twitter Inc+$902,818+1%
- Ionis Pharmaceuticals Inc+$568,565+5%
- Baidu−$42.7M−31%
- Block−$44.3M−43%
- Nvidia−$47.0M−52%
- Invitae Corp−$49.7M−34%
- Intellia Therapeutics Inc−$86.1M−52%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |